LO FRANCIS — SEC Form 4 filings
SEC reporting owner CIK 1780660. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-03-06 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 14 filings — 688,950 shares, $13,409,969 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 73.
- Largest priced transaction: sale of 107,537 shares @ $28.02 ($3,013,187) in Adaptive Biotechnologies Corp, filed 2026-09-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | Chief People Officer | 15 | — | 19 legs · 688,950 sh · $13,409,969 | 73 |
Form 4 filings — LO FRANCIS
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 53,091 @ $12.14 · Option exercise (M): 13,398 @ $8.46 · Option exercise (M): 15,629 @ $3.99 · Option exercise (M): 23,442 @ $8.12 · Sale (S): 107,537 @ $28.02 · Sale (S): 7,869 @ $28.57 · +4 more | EDGAR |
| 2026-07-17 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 59,374 @ $7.80 · Option exercise (M): 23,677 @ $12.14 · Option exercise (M): 22,711 @ $8.46 · Sale (S): 105,762 @ $22.59 · Option exercise (M): 59,374 (derivative) @ $0 · Option exercise (M): 23,677 (derivative) @ $0 · +1 more | EDGAR |
| 2026-07-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 3,500 @ $7.80 · Option exercise (M): 3,300 @ $12.14 · Option exercise (M): 12,206 @ $8.46 · Option exercise (M): 4,688 @ $3.99 · Option exercise (M): 14,064 @ $8.12 · Sale (S): 8,743 @ $22.18 · +13 more | EDGAR |
| 2026-06-08 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 5,792 @ $12.14 · Option exercise (M): 2,009 @ $8.46 · Option exercise (M): 2,344 @ $3.99 · Option exercise (M): 9,376 @ $8.12 · Sale (S): 39,741 @ $17.49 · Option exercise (M): 5,792 (derivative) @ $0 · +3 more | EDGAR |
| 2026-04-10 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 2,344 @ $3.99 · Sale (S): 22,564 @ $15.07 · Option exercise (M): 2,344 (derivative) @ $0 | EDGAR |
| 2026-03-13 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 30,593 @ $14.08 | EDGAR |
| 2026-03-09 | 4 | Adaptive Biotechnologies Corp (ADPT) | Sale (S): 38,074 @ $15.09 | EDGAR |
| 2026-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 44,063 @ $0 | EDGAR |
| 2026-01-14 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 36,650 @ $7.80 · Option exercise (M): 7,723 @ $12.14 · Option exercise (M): 21,002 @ $8.46 · Option exercise (M): 14,215 @ $3.99 · Sale (S): 79,590 @ $17.73 · Option exercise (M): 36,650 (derivative) @ $0 · +3 more | EDGAR |
| 2026-01-07 | 4/A | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 1,100 @ $7.80 · Option exercise (M): 1,100 @ $8.46 · Option exercise (M): 2,194 @ $3.99 · Sale (S): 4,394 @ $17.50 · Option exercise (M): 1,100 (derivative) @ $0 · Option exercise (M): 1,100 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 3,125 @ $3.99 · Sale (S): 3,125 @ $16.08 · Option exercise (M): 3,125 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 1,100 @ $7.80 · Option exercise (M): 2,194 @ $8.46 · Option exercise (M): 1,100 @ $3.99 · Sale (S): 4,394 @ $17.50 · Option exercise (M): 1,100 (derivative) @ $0 · Option exercise (M): 2,194 (derivative) @ $0 · +1 more | EDGAR |
| 2025-12-17 | 4 | Adaptive Biotechnologies Corp (ADPT) | Option exercise (M): 37,750 @ $7.80 · Option exercise (M): 19,423 @ $8.46 · Option exercise (M): 39,849 @ $3.99 · Sale (S): 113,890 @ $15.57 · Option exercise (M): 37,750 (derivative) @ $0 · Option exercise (M): 19,423 (derivative) @ $0 · +1 more | EDGAR |
| 2025-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 99,976 @ $0 · Sale (S): 7,085 @ $6.98 · Sale (S): 13,790 @ $6.99 · Grant/award (A): 150,024 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Adaptive Biotechnologies Corp (ADPT) | Grant/award (A): 99,976 @ $0 · Sale (S): 12,887 @ $3.43 · Sale (S): 1,813 @ $3.44 · Grant/award (A): 150,024 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1780660 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →